JW Pharmaceutical (XKRX:001067) DeferredTaxAndRevenue: ₩0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKRX:001067 JW Pharmaceutical XKRX:001067
85 GF Score
Price ₩48,750.00
GF Value ₩51,966.19
Valuation Fairly Valued
View Full Analysis

What is JW Pharmaceutical DeferredTaxAndRevenue?

JW Pharmaceutical XKRX:001067 -0.10% 85 DeferredTaxAndRevenue is ₩0 Mil as of Jun. 2026. GuruFocus rates XKRX:001067 with a GF Score™ of 85/100 and a GF Value™ of ₩51,966.19 (Fairly Valued).

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

JW Pharmaceutical's current deferred tax and revenue for the quarter that ended in Jun. 2026 was ₩0 Mil.

JW Pharmaceutical DeferredTaxAndRevenue Related Terms

JW Pharmaceutical DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for JW Pharmaceutical's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JW Pharmaceutical DeferredTaxAndRevenue Chart

JW Pharmaceutical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

JW Pharmaceutical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XKRX:001067
85GF Score
JW Pharmaceutical XKRX:001067
DeferredTaxAndRevenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of ₩0 Mil mean?
JW Pharmaceutical (XKRX:001067) has a DeferredTaxAndRevenue of ₩0 Mil as of Jun. 2026. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on JW Pharmaceutical.
Is JW Pharmaceutical's DeferredTaxAndRevenue too high?
JW Pharmaceutical's current DeferredTaxAndRevenue is ₩0 Mil. Overall, JW Pharmaceutical has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does JW Pharmaceutical's DeferredTaxAndRevenue compare to ZTS?
JW Pharmaceutical's DeferredTaxAndRevenue of ₩0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Drug Manufacturers company?
A good DeferredTaxAndRevenue depends on the Drug Manufacturers industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on JW Pharmaceutical. JW Pharmaceutical's current DeferredTaxAndRevenue is ₩0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JW Pharmaceutical stock overvalued right now?
Based on GuruFocus' analysis, JW Pharmaceutical (XKRX:001067) is currently considered Fairly Valued. The stock's GF Value™ is ₩51,966.19, compared to a current price of ₩48,750.00 — trading 6.2% below its estimated fair value. The current DeferredTaxAndRevenue is ₩0 Mil. JW Pharmaceutical's overall GF Score™ is 85/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For JW Pharmaceutical (XKRX:001067), the current DeferredTaxAndRevenue is ₩0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JW Pharmaceutical (XKRX:001067) Overvalued in 2026?

Based on GuruFocus' analysis, JW Pharmaceutical stock appears to be undervalued. The current stock price of ₩48,750.00 is trading 6.2% below its estimated GF Value™ of ₩51,966.19. GuruFocus considers JW Pharmaceutical to be Fairly Valued.

Key valuation signals for XKRX:001067:

  • DeferredTaxAndRevenue: ₩0 Mil
  • GF Value™: ₩51,966.19 vs. price of ₩48,750.00 (6.2% below fair value)
  • GF Score™: 85/100

No single metric tells the full story. See the XKRX:001067 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

JW Pharmaceutical Business Description

Address 2477, Nambusunhwan-ro, Seocho-gu, KOR
JW Pharmaceutical is active in the healthcare sector. It has been one of the leading companies in the pharmaceutical market on a global basis. Its original medicine and medical supply pipeline include Livalo, Thrupas, Sigmart and Actemra. It also develops low-protein and low-salt diet food for patients suffering from chronic renal insufficiency as well as general Pharmaceuticals and health care products.
85GF Score

Get the complete analysis for XKRX:001067

DeferredTaxAndRevenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₩48,750.00
Price
₩51,966.19
GF Value